Genomics

Dataset Information

DDO1002, an Nrf2–Keap1 inhibitor, improves impairedhaematopoiesis by reducing ROS production and promoting Nrf2-mediated antioxidative response


ABSTRACT: DDO1002, an Nrf2–Keap1 inhibitor, improves impairedhaematopoiesis by reducing ROS production and promoting Nrf2-mediated antioxidative response

PROVIDER: PRJNA1151641 | ENA |

REPOSITORIES: ENA